Poster Presentation October 27-29, 2011 Savannah, Georgia (CS-29) Abstract. Methods

Size: px
Start display at page:

Download "Poster Presentation October 27-29, 2011 Savannah, Georgia (CS-29) Abstract. Methods"

Transcription

1 Poster Presentation October 27-29, 2011 Savannah, Georgia (CS-29) Abstract Utility of Objective Measures of Activity and Analysis of Attention State in the Assessment of Therapeutic Response to Medications in Patients with ADHD: Community Care Perspective Henry Hasson, MD. Albert Einstein College of Medicine of Yeshiva University, Brooklyn, NY Objective: The NIMH Multimodal Treatment of ADHD Study (MTA) of 579 children with ADHD showed routine community care rendered only about 25% of these patients symptom free. This study is to determine the utility of objective measures of hyperactivity, impulsivity and inattention in a community care setting to achieve optimal therapeutic response to ADHD medications rapidly. Methods: Patients age 6 to 12 years old were evaluated by a board certified child neurologist. Patients with an established diagnosis of ADHD and new patients suspected of having ADHD were tested using the Quotient ADHD System, a 15-minute computer-based test that combines 6 measures of micro-motion with 13 results from an attention task. Patients meeting the DSM-IV criteria for ADHD were treated and re-assessed in 1-2 weeks. Results: Thirty-five children with at least 2 Quotient ADHD Tests were included in this series, including 8 children who were on medication for Test #1. 16 (45.7%) achieved normalized motion and attention metrics at the time of the second assessment; 6 (17.1%) achieved normalized motion control, but excessive inattention remained; 4 (11.4%) achieved normalized attention, but excessive hyperactivity remained; and 9 (25.7%) had excessive hyperactivity and inattention. 5 of the 15 patients with normalized motion and attention scores at the time of the second test, were previously treated, but not well controlled at baseline. Methods Conclusions: It is feasible and practical to implement an objective measurement of hyperactivity and analysis of shifts in attention state using the Quotient ADHD Test in a community care setting. Follow-up studies are needed to determine the time to optimal medication management compared to rating scales, and the impact on compliance, adherence and patient satisfaction. ADHD Assessment Protocol History, physical exam, clinical interview of patient, parent interview Objective, quantitative assessment with the Quotient System Quotient System: Kiosk Motion Tracking System Child Test: 1 target, 1 non-target 15 min. age 6-12, 20 min. ages Older Adolescent/Adult Test: 3 targets, 1 non-target, 20 min. Quotient System: Portable Reflector Motion Tracking System

2 The Quotient ADHD Test Report Motion Analysis Attention Analysis Attention State Analysis Scaled Scores & Global Score Results Total Boys Girls Number Mean Age at Test Range Avg. time between tests Medicated Motion & Attention Dyscontrol Baseline Category Motion Dyscontrol Only Attention Dyscontrol Only Motion & Attention in ref. range Test Motion and Attention 4 20 Motion Only 1 4 Attention Only 0 2 Normalized 3 1 Test days Motion and Attention Motion Only Attention Only Normalized Test days Motion and Attention Motion Only Attention Only Normalized Patients were classified into sub-groups according to the Scaled Scores for each test in order to compare baseline results with subsequent results. A Scaled Score >5 was defined as dyscontrol and <5 was defined as normalized. Examples: Test 1: Medicated (N=8): 4 children had motion and attention dyscontrol, 1 had motion dyscontrol but normal attention, 3 were normalized. Not Medicated: 20 children had attention and motion dyscontrol, 4 had motion dyscontrol only, 2 had attention dyscontrol only, 1 was normalized. Test #2 was 13.1 days (on average) after test 1. Medicated (N=8): 3 children had motion and attention dyscontrol, 5 were normalized. Not Medicated: For the 20 children had attention and motion dyscontrol, 6 had motion and attention dyscontrol, 4 had motion dyscontrol only, 5 had attention deficit only and 5 were normalized. 4 had motion dyscontrol only, 2 had attention dyscontrol only, 1 was normalized.

3 Success to me is......finding the best treatment plan to help Josh get back on track. Henry J. Hasson, MD Pediatric Neurology, Brooklyn, NY History: Josh is a 7 year old boy in the 1st grade. History and exam revealed good health. The mother noted that he kicked a lot more than his siblings. His growth and development are age appropriate. Referral Complaint: His first visit was February 5. He presented with complaints of hyperactivity and inattention at home and at school. He was failing quizzes and tests. Plan of Action: Shortly after Josh s initial visit, our practice acquired the Quotient System. We administered a Quotient ADHD Test while on Concerta 27 mg at the first follow-up visit on 2/27. Motion and attention metrics revealed significant motion dyscontrol, with the disengaged attention state dominating. His mother reported no improvement in behavior at home or school. Clinical interview, parent report and Quotient results all pointed to ineffective medication or sub-therapeutic dose, so we increased dose to Concerta 36 mg. We repeated Quotient Test on 3/13. His mother reported that hyperactivity improved, but he could not pay attention in school or follow directions at home. We increased dose to Concerta 54 mg. On April 3, the Quotient Test confirmed adequate dosing. His mother reported that his teachers were happy with his progress. He is doing wonderfully at school and at home, with good motion control and attention. Conclusions: This case illustrates the value of using data from serial, objective assessments using the Quotient ADHD Test during medication initiation. The reports help the parent and patient see their progress (or lack of progress) in a concrete way, which makes the conversation about next steps more efficient and productive. Objective data helps us to optimize the treatment plan faster.

4 Josh, Age 7 Test #1, 2/27 Concerta 27 mg, 2 hours post-dose Motion Analysis Immobility Duration Test #1 Test #2 Test # ms 94 ms ms ms 95 Movements Displacement m 6.12 m m m 91 Area cm cm cm cm 2 67 Spatial Complexity Temporal Scaling Two of six motion results at baseline were less than the 35 th percentile, which may be clinically significant. Results improved in Test #2 with all metrics above the 50th percentile. Results improved further in Test #3. Metrics were within the reference range. Graphics reveal that performance deteriorated. Attention Analysis Test #1 Test #2 Test #3 Accuracy % 58.4% 11 t 60.9% 15 t 87.1% 76 Omission errors % 43.1% 2 t 36.5% 3 t 3.0% 61 Commission errors % 40.0% % % 70 Latency ms 692 ms ms ms 45 Variability ms 447 ms 1 t 340 ms 2 t 157 ms 63 COV t 74 2 t Test #1: Accuracy, omission errors, variability and COV were <16th percentile at Test #1. The latency score (692 ms) was just outside the reference range and slow for his age group. These results suggest that the medication is at a sub-therapeutic dose. Test #2: With the exception of commission errors and latency, the attention metrics are still more than 1 standard deviation from the mean. Test #3: All metrics are well within the reference range. Attention State Summary Many omission and commission errors throughout the test, with more omission errors at end of the test. Slow and variable responses. Test #1 Test #2 Test #3 # Shifts Attentive % 0.0% 1 t 0.0% 1 t 43.3% 70 Impulsive % 13.3% % % 39 Distracted % 26.7% 14 t 23.3% % 56 Disengaged Random % 26.7% % % 75 Minimal % 33.3% 2 t 26.7% 2 t 0.0% 99 Contrary % 0.0% % % 99 The first two tests, there were 2 parameters <16th percentile and 2 between the 17th and 35th percentile. He had good performance in Test #3. Distracted and disengaged attention states dominate the test. What else might cause this?

5 Test #2, 3/13 Concerta 36 mg, 2 hours post-dose Test #3 4/3 Concerta 54 mg, 5 hours post-dose Motion Scaled Score improved, but is above the mean for subjects without ADHD (4.0). Motion control is good for a 7 year old (high percentile scores, tight motion pattern throughout.) Response Results Motion Results Many omission errors at the beginning and end of the test. Slow/variable correct responses. Omission errors reduced. Many commission errors. Improved accuracy from 3-12 minutes. Distracted and disengaged attention states dominate the test. Medication is sub-therapeutic. Much better on-task behavior (43.3%, 70th %ile). Room for improvement. Attention State Results

6 Quotient ADHD Composite Scores Test #1 Test #2 Test #3 Test Date 2/27/2011 3/13/2011 4/3/2011 Age Medication Concerta 27 mg Concerta 36 mg Concerta 54 mg System Index Likely Likely Unlikely Scaled Scores Motion System Index Key Unlikely Possible Probable Likely Scaled Scores Key Attention Global mean non-adhd=4 mean ADHD=7 Case Summary February 5: This boy was a new patient. Presented with complaints of hyperactivity and inattention at home and at school. He was failing quizzes and tests. Started Concerta 27 mg February 27: The first Quotient ADHD Test was administered 3 weeks later while on medication. Motion and attention metrics revealed significant motion dyscontrol, with Disengaged attention state dominating. Mother reported no improvement in behavior at home or school. Clinical interview, parent report and Quotient results pointed to ineffective or sub-therapeutic medication. Increased dose to Concerta 36 mg. March 13: Repeated Quotient Test. Mother reported that hyperactivity improved, but he still cannot pay attention in school or follow directions at home. Increased dose to Concerta 54 mg. April 3: Quotient Test confirmed adequate dosing. Mother reported that his teachers were happy with his progress. He is doing wonderfully at school and at home, with good motion control and attention. 1- AAP ADHD Clinical Practice Guideline. Pediatrics, (5). 2- AACAP Practice Parameter. J. Am. Acad. Child Adoles. Psychiatry, (7). 3- Data on file. 4- Teicher, J of Child and Adol. Psychopharmacology, (1). Copyright 2011 F8060 (2011/12/26) Quotient is a registered trademark of BioBehavioral Diagnostics Company. Concerta is a registered trademark of McNeil Pharmaceuticals

7 Success to me is......finding medication to help Scott focus after school. Henry J. Hasson, MD Pediatric Neurology, Brooklyn, NY History: Scott is a 12 year old boy in the 7th grade. He has been a patient since July 2010 when I made a diagnosis of ADHD. Referral Complaint: Scott was doing fairly well on 15 mg Focalin XR, but his mother noticed that he became distracted late in the afternoon and had trouble finishing homework. Plan of Action: We asked Scott to refrain from taking his medication on the day of his next visit so we could do a baseline Quotient ADHD Test. A baseline test on a new patient gives us quantitative severity measures in each symptom domain and serves as a benchmark to guide decision-making about patient management. The baseline test is also valuable for established patients to determine if deficits are severe enough to continue medication. Scott s baseline test showed good motion control in the first five minutes, but performance degraded progressively. The mean motion metrics were all at the low end of the reference range. There were 21 attention shifts. Distraction and disengagement were the predominant attention states at the end of the test. We re-started Focalin XR 15 mg and repeated the Quotient assessment on March 14. He had excellent motion control, but still some inattention at school. Inattention was worse at the end of the day, which suggested that the medication may be wearing off too early. We switched to Concerta 54 mg to cover late afternoon. At Scott s back-to-school visit on October 2, the Quotient Test confirmed adequate dosing. He returned to school in September taking his medication. Although I was unaware of it at the time, because he had a new teacher, the parents decided to try a no medication experiment. The teacher immediately saw a difference in behavior and called the parents to report the problems. Conclusions: This case illustrates the value of using data from serial, objective assessments using the Quotient ADHD Test to inform medical management of the patient and help to achieve better clinical efficacy. We can confirm suspicions of medication wearing off and adjust by adding a dose later in the day or by changing to a longer acting medication, as we decided for Scott.

8 Scott, Age 12, Grade 7 Test #1, 3/6 No medication Motion Analysis Immobility Duration Baseline Test #2 Test # ms 146 ms ms ms 91 Movements Displacement m 3.59 m m m 94 Area cm 2 91 cm cm cm 2 96 Spatial Complexity Temporal Scaling Four of six motion results at baseline were less than the 35 th percentile, which may be clinically significant. The age/gender matched percentile scores improved to >90th percentile in Test #2 and Test #3. Metrics were at the low end of the reference range. Area increased over time. Attention Analysis Baseline Test #2 Test #3 Accuracy % 79.3% % % 81 Omission errors % 15.2% 15 t 5.3% % 48 Commission errors % 25.7% % % 81 Latency ms 486 ms ms ms 76 Variability ms 164 ms ms ms 70 COV Test #1: Omission errors were <16th percentile at Test #1. Test #2: Attention metrics improved, but the graphic reveals that the number of omission errors increased at in the last 5 minutes of the test. Test #3: All metrics are within the reference range. Attention State Summary Appropriately attentive responses in the first 5 minutes, with some commission errors. Latency and omission errors increase at end. Baseline Test #2 Test #3 # Shifts t Attentive % 26.7% % % 83 Impulsive % 40.0% % % 79 Distracted % 20.0% 11 t 16.7% 16 t 6.7% 56 Disengaged Random % 6.7% % % 99 Minimal % 6.7% 12 t 0.0% % 99 Contrary % 0.0% % % 99 In Test #1, there were many attention state shifts (21, 7th percentile) and the percentage of time in the Attentive state was low (26.7%, 28th percentile. Metrics improved in Test #2 and was excellent in Test #3. The Impulsive state results from many commission errors. The patient was Distracted/Disengaged for most of the last 5 minutes.

9 Test #2, 3/14 Focalin XR 15 mg, 4 hrs post-dose Test #3, 10/2 Concerta 54 mg, 1.5 hrs post-dose Excellent motion control. Excellent motion control. Response Results Motion Results Improved attentive behavior, with omission errors at the low end of the reference range for age/gender. Very good attentive behavior. 16 ttention state shifts is a pattern consistent with ADHD. Distracted state is at the 16th %ile for a 12 year-old boy. Very good Attentive behavior. Attention State Results

10 Quotient ADHD Composite Scores Test #1 Test #2 Test #3 Test Date 3/6/2011 3/14/ /2/2011 Age Medication None Focalin XR 15 mg Concerta 54 mg System Index Likely Unlikely Unlikely Scaled Scores Motion System Index Key Unlikely Possible Probable Likely Scaled Scores Key Attention Global mean non-adhd=4 mean ADHD=7 Case Summary This boy has been in the practice since July. He was stable on Focalin XR 15 mg. Teacher and parent reports were positive. March 6: A baseline Quotient ADHD test was administered without medication. Mother wanted to confirm that medication was still needed. The motion pattern showed good control in the first five minutes with progressive degradation. The mean motion metrics were all at the low end of the reference range. There were 21 attention shifts. Distraction and Disengagement were the predominant attention states at the end of the test. We re-started Focalin XR 15 mg. March 14: Repeated Quotient Test. Excellent motion control, but still some inattention at school. Inattention was worse at the end of the day, which indicated that the medication may be wearing off early. Switched medication to Concerta 54 mg to cover late afternoon. October 2: Quotient Test confirmed adequate dosing. The boy returned to school taking his medication. Because he had a new teacher, the parents decided to try a no medication experiment. The teacher immediately saw a difference in behavior and called the parents to report the problems. Conclusions Objective testing reduced time to medication optimization from approximately 3-6 months to 4-8 weeks Baseline testing off medication quantifies the severity of deficit and makes the conversation with the parent and patient more efficient and productive. Reassessments at 1-2 week intervals during medication initiation helps to guide treatment decisions and can help to achieve optimal dosing faster. Repeat tests inform decisions when considering changing medication or adjusting dose. Back-to-school assessments confirm that medication is still needed to control symptoms. Copyright 2012 F8074 (2012/04/05) Quotient is a registered trademark of BioBehavioral Diagnostics Company. Focalin is a registered trademark of Novartis Pharmaceuticals. Concerta is a registered trademark of McNeil Pharmaceuticals

Every person with ADHD has a unique portrait.

Every person with ADHD has a unique portrait. Every person with ADHD has a unique portrait. Now you can see it objectively. The Quotient ADHD System accurately measures motion and analyzes shifts in attention state to give an objective picture of

More information

ADHD NICE guidelines and standard treatments

ADHD NICE guidelines and standard treatments ADHD NICE guidelines and standard treatments Professor Chris Hollis, Consultant in Developmental Neuropsychiatry Developmental Psychiatry Section Division of Psychiatry University of Nottingham Declarations

More information

ADHD Diagnosis and Evaluation Robin K. Blitz, MD. ADHD DIAGNOSTIC CLINIC Week 1

ADHD Diagnosis and Evaluation Robin K. Blitz, MD. ADHD DIAGNOSTIC CLINIC Week 1 ADHD Diagnosis and Evaluation Robin K. Blitz, MD ADHD DIAGNOSTIC CLINIC Week 1 ADHD What is it? A neurodevelopmental disorder Developmentally inappropriate levels of hyperactivity, impulsivity, and inattention

More information

Maximizing the Benefits of Stimulant Medication Treatment for Children with AD/HD

Maximizing the Benefits of Stimulant Medication Treatment for Children with AD/HD Maximizing the Benefits of Stimulant Medication Treatment for Children with AD/HD by David Rabiner, Ph.D. Center for Child and Family Policy Duke University Support for distributing this report is provided

More information

ADDES-S QUICK SCORE SECONDARY-AGE SCHOOL VERIONPROFILE SAMPLE

ADDES-S QUICK SCORE SECONDARY-AGE SCHOOL VERIONPROFILE SAMPLE Student name: Austin P. Williams School: Midvale Jr. High Class: English Gender: City: Midvale State: Date of rating: 1996 1 Date of birth: Age at rating: 1 (years) Rated by (observer's name): Comments:

More information

Managing ADHD with Co-Occurring Anxiety Disorders in Primary Care

Managing ADHD with Co-Occurring Anxiety Disorders in Primary Care Managing ADHD with Co-Occurring Anxiety Disorders in Primary Care February 19, 2015 Andrew J. Barnes, MD, MPH, FAAP Assistant Professor Kristen Aggerbeck Kessler, MD, MPH Developmental-Behavioral Pediatrics

More information

Caring for Children With ADHD: A Resource Toolkit for Clinicians

Caring for Children With ADHD: A Resource Toolkit for Clinicians INTRODUCTION Attention-deficit/hyperactivity disorder (ADHD) is one of the most common chronic childhood disorders. Current estimates indicate that 4% to 12% of all school-aged children may be affected.

More information

Finally, a clear picture of ADHD. Your guide to objective testing and treatment.

Finally, a clear picture of ADHD. Your guide to objective testing and treatment. Finally, a clear picture of ADHD. Your guide to objective testing and treatment. Information provided by: Every person with ADHD tells a story. Could your child have Attention Deficit Hyperactivity Disorder

More information

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic. bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.

More information

Attention-Deficit Disorders Evaluation Scale Second Edition, School Version

Attention-Deficit Disorders Evaluation Scale Second Edition, School Version Attention-Deficit Disorders Evaluation Scale Second Edition, School Version (ADDES-2, SV) The Attention-Deficit Disorders Evaluation Scale Second Edition, School Version (J. McCarney, 1995b), is a rating

More information

Policy criteria are met. The. methylphenidate extended-re. When Policy prior to the. Spansules,

Policy criteria are met. The. methylphenidate extended-re. When Policy prior to the. Spansules, ADHDD Stimulantt Step Therapy Program Policy Number: 5.01.592 Origination: 07/2014 Last Review: 07/2014 Next Review: 07/2015 Policy BCBSKC will provide coverage for brand name ADHD stimulant medications

More information

ADHD Monitoring System

ADHD Monitoring System ADHD Monitoring System by David Rabiner, Ph.D. Duke University The ADHD Monitoring System is intended to help parents and health care professionals monitoring the ongoing effectiveness of treatment(s)

More information

Continuous Performance Test 3 rd Edition. C. Keith Conners, Ph.D.

Continuous Performance Test 3 rd Edition. C. Keith Conners, Ph.D. Continuous Performance Test 3 rd Edition C. Keith Conners, Ph.D. Assessment Report Name/ID: Alexandra Sample Age: 16 Gender: Female Birth Date: February 16, 1998 Grade: 11 Administration Date: February

More information

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic. Attention deficit hyperactivity disorder in children and young people bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to

More information

NQF-Endorsed Behavioral Health Measures. Title Description Steward

NQF-Endorsed Behavioral Health Measures. Title Description Steward 0003 Bipolar Disorder: Assessment for Diabetes Percentage of patients treated for bipolar disorder who are assessed for diabetes within 16 weeks after initiating treatment with an atypical antipsychotic

More information

Management of Attention Deficit/Hyperactivity Disorder (ADHD) How the Pharmacist Can Impact Care

Management of Attention Deficit/Hyperactivity Disorder (ADHD) How the Pharmacist Can Impact Care Management of Attention Deficit/Hyperactivity Disorder (ADHD) How the Pharmacist Can Impact Care POSTTTEST/RATIONALE Case I The parents of a boy, 4 years of age ask the pharmacist for consultation about

More information

ADHDInitiative. The Vermont A MULTIDISCIPLINARY APPROACH TO ADHD FOR FAMILIES/CAREGIVERS, EDUCATIONAL & HEALTH PROFESSIONALS

ADHDInitiative. The Vermont A MULTIDISCIPLINARY APPROACH TO ADHD FOR FAMILIES/CAREGIVERS, EDUCATIONAL & HEALTH PROFESSIONALS The Vermont ADHDInitiative A MULTIDISCIPLINARY APPROACH TO ADHD FOR FAMILIES/CAREGIVERS, EDUCATIONAL & HEALTH PROFESSIONALS ACKNOWLEDGEMENTS: This work and its resulting improvements in the care provided

More information

ADHD Preference and Goal Instrument (ADHD PGI) Instructions: By using the ADHD PGI, you agree to the following:

ADHD Preference and Goal Instrument (ADHD PGI) Instructions: By using the ADHD PGI, you agree to the following: ADHD Preference and Goal Instrument (ADHD PGI) Instructions: By using the ADHD PGI, you agree to the following: 1. Any copies made of the ADHD PGI for use with patients or in research must appear exactly

More information

Diagnosis and Treatment of ADHD

Diagnosis and Treatment of ADHD Diagnosis and Treatment of ADHD Steven R. Pliszka, MD Professor and Chair Department of Psychiatry The University of Texas Health Science Center at San Antonio Speaker Disclosure Dr. Pliszka has disclosed

More information

The Distracted Student Attention Deficit Hyperactivity Disorder. Materials for Learners

The Distracted Student Attention Deficit Hyperactivity Disorder. Materials for Learners Materials for Learners Packet should include the following: Handout #1: Diagnostic Features of ADHD (Adapted from DSM V) Handout #2: Parent and Teacher Completed Vanderbilt Rating Scales Clinical pearls

More information

Pharmacy Medical Necessity Guidelines: CNS Stimulant Medications

Pharmacy Medical Necessity Guidelines: CNS Stimulant Medications Pharmacy Medical Necessity Guidelines: CNS Stimulant Medications Effective: January 1, 2017 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy

More information

ADHD Treatment Medication Robin K. Blitz, MD. ADHD DIAGNOSTIC CLINIC Week 2

ADHD Treatment Medication Robin K. Blitz, MD. ADHD DIAGNOSTIC CLINIC Week 2 ADHD Treatment Medication Robin K. Blitz, MD ADHD DIAGNOSTIC CLINIC Week 2 Treatment Should you treat ADHD? Effective treatment for ADHD is imperative! ADHD is one of the MOST COMMON disorders treated

More information

Attention-Deficit / Hyperactivity Disorder (ADHD)

Attention-Deficit / Hyperactivity Disorder (ADHD) Attention-Deficit / Hyperactivity Disorder (ADHD) OBJECTIVE To provide evidence-based recommendations for the management of Attention Deficit Hyperactivity Disorder (ADHD). INTRODUCTION Attention Deficit

More information

Clinical Practice Guidelines: Attention Deficit/Hyperactivity Disorder

Clinical Practice Guidelines: Attention Deficit/Hyperactivity Disorder Clinical Practice Guidelines: Attention Deficit/Hyperactivity Disorder AACAP Official Action: OUTLINE OF PRACTICE PARAMETERS FOR THE ASSESSMENT AND TREATMENT OF CHILDREN, ADOLESCENTS, AND ADULTS WITH ADHD

More information

WHAT IS ATTENTION DEFICIT HYPERACTIVITY DISORDER?

WHAT IS ATTENTION DEFICIT HYPERACTIVITY DISORDER? INFORMATION FOR PATIENTS TAKING FOCALIN XR, OR FOR THEIR PARENTS OR CAREGIVERS Once Daily Focalinª XR (dexmethylphenidate hydrochloride) extended-release capsules This information for patients or their

More information

There are significant differences between the brain functioning in people with ADHD compared to those who are not.

There are significant differences between the brain functioning in people with ADHD compared to those who are not. In my previous writing on ADHD I talked about the major characteristics of the disorder, including both the predominant features that determine the diagnosis, as well as other difficulties that research

More information

For more than 100 years, extremely hyperactive

For more than 100 years, extremely hyperactive 8 WHAT WE KNOW ADHD Predominantly Inattentive Type For more than 100 years, extremely hyperactive children have been recognized as having behavioral problems. In the 1970s, doctors recognized that those

More information

Summary of IVA-2 Research Studies

Summary of IVA-2 Research Studies Summary of IVA-2 Research Studies The IVA+Plus and IVA-2 test procedures, structure and quotient scales are the same. Since the test itself, including the norms, have not changed, all of the original reliability

More information

RESEARCH OBJECTIVE/QUESTION

RESEARCH OBJECTIVE/QUESTION ADHD 9 Study results from confirm effectiveness of combined treatments and medication management in reducing children s Attention Deficit/Hyperactivity Disorder (ADHD) symptoms CITATION: MTA Cooperative

More information

ADHD. Information for parents

ADHD. Information for parents ADHD Information for parents Disclosure I am a general pediatrician with no special training in the diagnosis or treatment of ADHD or coexisting mental health issues. My goal is to provide general information

More information

Services for youngsters with ADHD and related disorders: Status and policy

Services for youngsters with ADHD and related disorders: Status and policy Services for youngsters with ADHD and related disorders: Status and policy Conference: Family polices and child welfare in the Nordic countries 5.9. 2014 For clarification Youngsters Children aged 5 to

More information

Integrated Visual and Auditory (IVA) Continuous Performance Test

Integrated Visual and Auditory (IVA) Continuous Performance Test DISCLAIMER The information contained within this document does not constitute medical advice or diagnosis and is intended for education and information purposes only. It was current at the time of publication

More information

What is ADHD/ADD and Do I Have It?

What is ADHD/ADD and Do I Have It? What is ADHD/ADD and Do I Have It? ADHD Definition and Symptoms Adults with ADHD Possible Coexistent Conditions Medications and Treatments Additional Resources Works Cited What is Attention Deficit Hyperactivity

More information

Attention-Deficit / Hyperactivity Disorder (ADHD)

Attention-Deficit / Hyperactivity Disorder (ADHD) Attention-Deficit / Hyperactivity Disorder (ADHD) OBJECTIVE To provide evidence-based recommendations for the management of Attention Deficit Hyperactivity Disorder (ADHD). INTRODUCTION Attention Deficit

More information

Could Your Child Have ADHD?

Could Your Child Have ADHD? Could Your Child Have ADHD? From ADDitude s Experts TERMS OF USE Copyright 2013 by New Hope Media. All rights reserved. No part of this report may be reproduced or transmitted in any form or by any means,

More information

Innovative Therapies for ADD, ADHD, LD:

Innovative Therapies for ADD, ADHD, LD: Innovative Therapies for ADD, ADHD, LD: New Computer-Based Technology to Treat Attention Deficit Disorders By Bob Gottfried PhD Background It is estimated that over 5% of all children in North America

More information

UCLA-NPI/VA PG-2 Child & Adolescent Psychiatry Course 2004-5. Week 3:Attention Deficit Hyperactivity Disorder

UCLA-NPI/VA PG-2 Child & Adolescent Psychiatry Course 2004-5. Week 3:Attention Deficit Hyperactivity Disorder UCLA-NPI/VA PG-2 Child & Adolescent Psychiatry Course 2004-5 Week 3:Attention Deficit Hyperactivity Disorder ADHD:Epidemiology Point Prevalence 2-18% M:F>= 2:1 ADHD Symptoms Cognitive (attention) Impulsivity

More information

University of Southern California Attention Deficit and Hyperactivity Disorder (ADHD) Policy

University of Southern California Attention Deficit and Hyperactivity Disorder (ADHD) Policy University of Southern California Attention Deficit and Hyperactivity Disorder (ADHD) Policy I. Purpose: To provide high quality care to USC students with Attention Deficit Hyperactivity Disorder and guidance

More information

Treatment Options for ADHD in Children and Teens. A Review of Research for Parents and Caregivers

Treatment Options for ADHD in Children and Teens. A Review of Research for Parents and Caregivers Treatment Options for ADHD in Children and Teens A Review of Research for Parents and Caregivers Is This Summary Right for Me? Yes, if: A doctor said that your child or teen has attention deficit hyperactivity

More information

Update on ADHD: AAP Revised Guidelines

Update on ADHD: AAP Revised Guidelines Disclosures Update on ADHD: AAP Revised Guidelines I have no financial relationships to disclose. Neha Patel, DO Developmental and Behavioral Pediatric Fellow, PGY 6 September 12, 2014 Learning Objectives

More information

Attention Deficit Hyperactivity Disorder (ADHD) Newsletter

Attention Deficit Hyperactivity Disorder (ADHD) Newsletter Attention Deficit Hyperactivity Disorder (ADHD) Newsletter Joey s Story Joey is a typical seventh grader. He likes to play sports and spend time with his friends. He enjoys video games and eating pizza.

More information

Conners' Continuous Performance Test II (CPT II V.5)

Conners' Continuous Performance Test II (CPT II V.5) Conners' Continuous Performance Test II (CPT II V.5) By C. Keith Conners, Ph.D. and MHS Staff CPT II/CRS-R Multimodal Integrated Report This report is intended to be used by the test administrator as an

More information

TOOL KIT FOR THE MANAGEMENT OF ADULT ATTENTION DEFICIT/ HYPERACTIVITY DISORDER (ADHD)

TOOL KIT FOR THE MANAGEMENT OF ADULT ATTENTION DEFICIT/ HYPERACTIVITY DISORDER (ADHD) TOOL KIT FOR THE MANAGEMENT OF ADULT ATTENTION DEFICIT/ HYPERACTIVITY DISORDER (ADHD) TOOL KIT FOR THE MANAGEMENT OF ADULT ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) The clinical tool kit is intended

More information

Attention Deficit/ Hyperactivity Disorder

Attention Deficit/ Hyperactivity Disorder Attention Deficit/ Hyperactivity Disorder Does your child have trouble paying attention? Does he or she talk nonstop or have trouble staying still? Does your child have a hard time controlling his or her

More information

Cognitive Behavior Therapy for Children with Attention Deficit Hyperactivity Disorder. Monica Mongia, PhD Lily Hechtman, MD, F.R.C.P.

Cognitive Behavior Therapy for Children with Attention Deficit Hyperactivity Disorder. Monica Mongia, PhD Lily Hechtman, MD, F.R.C.P. Cognitive Behavior Therapy for Children with Attention Deficit Hyperactivity Disorder Monica Mongia, PhD Lily Hechtman, MD, F.R.C.P. 2 Introduction ADHD - lifelong developmental disorder (Kessler et al,

More information

One Dose Lasts. Information for parents about Concerta, the. once-daily medication for children with Attention Deficit Hyperactivity Disorder (ADHD).

One Dose Lasts. Information for parents about Concerta, the. once-daily medication for children with Attention Deficit Hyperactivity Disorder (ADHD). One Dose Lasts FROM HOME TO HOMEWORK PARENTS: Make sure you read the important information about Concerta (methylphenidate HCl) Extended-release Tablets below. To remove, just peel off. Information for

More information

ADHD: Does My Child Have It?

ADHD: Does My Child Have It? ADHD: Does My Child Have It? What are the signs of ADHD? ADHD stands for attention-deficit hyperactivity disorder. Children with ADHD may have hyperactive behavior, a lack of attention and difficulty concentrating.

More information

SAMPLE. Conners 3 Parent Assessment Report. By C. Keith Conners, Ph.D.

SAMPLE. Conners 3 Parent Assessment Report. By C. Keith Conners, Ph.D. By C. Keith Conners, Ph.D. Conners 3 Parent Assessment Report This Assessment report is intended for use by qualified assessors only, and is not to be shown or presented to the respondent or any other

More information

Tool Kit for Management of Adult ADHD

Tool Kit for Management of Adult ADHD Tool Kit for Management of Adult ADHD Tool Kit for Management of Adult ADHD The clinical tool kit is intended to assist the PCP in assessing the needs of the adults age 18 and over regarding depression

More information

Attention-Deficit/Hyperactivity Disorder (ADHD) Clinical Practice Guideline

Attention-Deficit/Hyperactivity Disorder (ADHD) Clinical Practice Guideline Children ages 4 18 Attention-Deficit/Hyperactivity Disorder (ADHD) Clinical Practice Guideline Attention-deficit/ hyperactivity disorder (ADHD) continues to be the most common neurobehavioral disorder

More information

Attention-Deficit Disorders Evaluation Scale Home Version (ADDES-HV)

Attention-Deficit Disorders Evaluation Scale Home Version (ADDES-HV) Attention-Deficit Disorders Evaluation Scale Home Version (ADDES-HV) The Attention-Deficit Disorder Evaluation Scale Home Version (J. McCarney, 1995a) is a counterpart of the Attention-Deficit Disorders

More information

Diagnosis and Treatment of ADHD in Children and Adolescents Clinician Guide MARCH 2016

Diagnosis and Treatment of ADHD in Children and Adolescents Clinician Guide MARCH 2016 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Diagnosis and Treatment of ADHD in Children and Adolescents Clinician Guide MARCH 2016 Introduction This Clinician Guide was developed to assist

More information

Conners' Continuous Performance Test II (CPT II V.5)

Conners' Continuous Performance Test II (CPT II V.5) Conners' Continuous Performance Test II (CPT II V.5) By C. Keith Conners, Ph.D., Drew Erhardt, Ph.D., Elizabeth Sparrow, Ph.D., and MHS Staff CPT II/CAARS Multimodal Integrated Report This report is intended

More information

Tool Kit for Childhood & Adolescent ADHD Management

Tool Kit for Childhood & Adolescent ADHD Management Tool Kit for Childhood & Adolescent ADHD Management Clinical Tool Kit for the Management of Childhood & Adolescent Attention-Deficit/Hyperactivity Disorder (ADHD) The clinical tool kit is intended to assist

More information

Preferred Practice Guidelines. Behavioral Health Screening, Assessment and Treatment

Preferred Practice Guidelines. Behavioral Health Screening, Assessment and Treatment Preferred Practice Guidelines Behavioral Health Screening, Assessment and Treatment This guideline is based in part on the following: American Academy of Pediatrics. ADHD: Clinical Practice Guideline for

More information

Dan DaSilva, Ph.D. Morris Psychological Group Rutgers University, Graduate School of Education Atlantic Neuroscience Insitute

Dan DaSilva, Ph.D. Morris Psychological Group Rutgers University, Graduate School of Education Atlantic Neuroscience Insitute Assessment of the ADHD (not) Pilot Dan DaSilva, Ph.D. Morris Psychological Group Rutgers University, Graduate School of Education Atlantic Neuroscience Insitute Demographics 15 year, 10 month-old male

More information

EEG Biofeedback: A New Treatment Option For ADD/ADHD

EEG Biofeedback: A New Treatment Option For ADD/ADHD EEG Biofeedback: A New Treatment Option For ADD/ADHD Marabella A. Alhambra, M.D., Timothy P. Fowler, and Antonio A. Alhambra, M.D. Attention Deficit Disorder is commonly treated with stimulant medications

More information

Summary of IVA-QS Research Studies

Summary of IVA-QS Research Studies Summary of IVA-QS Research Studies The IVA+Plus and IVA-QS test procedures, structure and quotient scales are essentially the same. Howeverr, the IVA-QS differs in that it is limited to the first 300 trials

More information

The Role of Medication

The Role of Medication Managing Medication for Children and Adolescents with ADHD Treating ADHD in children requires medical, educational, behavioral and psychological interventions. This comprehensive approach to treatment

More information

PATIENT SAFETY PROGRAM Section 9. Patient Safety Program

PATIENT SAFETY PROGRAM Section 9. Patient Safety Program Patient Safety WellCare is committed to offer services that ensure the safe delivery of clinical care to its members. WellCare s Patient Safety Plan exists to establish the framework for demonstrating

More information

Conners' Continuous Performance Test II (CPT II V.5)

Conners' Continuous Performance Test II (CPT II V.5) Conners' Continuous Performance Test II (CPT II V.5) By C. Keith Conners, Ph.D. and MHS Staff Profile Report This report is intended to be used by the test administrator as an interpretive aid. This report

More information

ADHD PRACTISE PARAMETER. IRSHAAD SHAFFEEULLAH, M.D. A diplomate American Board of CHILD AND ADOLESCENT PSYCHIATRY

ADHD PRACTISE PARAMETER. IRSHAAD SHAFFEEULLAH, M.D. A diplomate American Board of CHILD AND ADOLESCENT PSYCHIATRY ADHD PRACTISE PARAMETER IRSHAAD SHAFFEEULLAH, M.D. A diplomate American Board of CHILD AND ADOLESCENT PSYCHIATRY Similar type of idea Similar document Similar document AACAP document Neurobiological condition

More information

Do Stimulant Medications Improve Educational and Behavioral Outcomes for Children with ADHD? Janet Currie, Mark Stabile, Lauren Jones

Do Stimulant Medications Improve Educational and Behavioral Outcomes for Children with ADHD? Janet Currie, Mark Stabile, Lauren Jones Do Stimulant Medications Improve Educational and Behavioral Outcomes for Children with ADHD? Janet Currie, Mark Stabile, Lauren Jones Motivation Over past 20 years, mental health disabilities have overtaken

More information

ADHD and School Failure

ADHD and School Failure ADHD and School Failure Your child isn t doing well in school. Actually, she/he s never done very well, but it s getting worse as schoolwork gets more challenging every year. What do you do? Here are some

More information

ADHD: More than Medications

ADHD: More than Medications ADHD: More than Medications David C. Rettew, M.D. Associate Professor of Psychiatry and Pediatrics Director, Pediatric Psychiatry Clinic Director, Child Psychiatry Fellowship University of Vermont, College

More information

Q: What is the difference between ADD and ADHD?

Q: What is the difference between ADD and ADHD? These are the ten most frequently asked questions I receive about ADD/ADHD: Q: What is ADHD? A: Attention deficit hyperactivity disorder (ADHD), or just attention deficit disorder (ADD) are confusing medical

More information

Autism Spectrum Disorder: Latest in Prevalence, Diagnosis and Interventions

Autism Spectrum Disorder: Latest in Prevalence, Diagnosis and Interventions Autism Spectrum Disorder: Latest in Prevalence, Diagnosis and Interventions Muhammad Waqar Azeem, MD, DFAACAP, DFAPA Chair, Department of Psychiatry Sidra Medical & Research Center DISCLOSURES: NONE n

More information

Conners' Teacher Rating Scales Revised: Long (CTRS R:L)

Conners' Teacher Rating Scales Revised: Long (CTRS R:L) Conners' Teacher Rating Scales Revised: Long (CTRS R:L) By C. Keith Conners, Ph.D. Interpretive Report Copyright 2002, Multi-Health Systems Inc. All rights reserved. P.O. Box 950, North Tonawanda, NY 14120-0950

More information

Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention Deficit/Hyperactivity Disorder in Children and Adolescents

Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention Deficit/Hyperactivity Disorder in Children and Adolescents Prepared for your next patient. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention Deficit/Hyperactivity Disorder in Children and Adolescents Mark L. Wolraich, MD, FAAP

More information

MENTAL HEALTH ATTENTION DEFICIT/ HYPERACTIVITY DISORDER

MENTAL HEALTH ATTENTION DEFICIT/ HYPERACTIVITY DISORDER MENTAL HEALTH ATTENTION DEFICIT/ HYPERACTIVITY DISORDER WHAT IS ADHD? Attention deficit/hyperactivity disorder (ADHD) is a common behavioral problem in children. It is estimated that between 3 percent

More information

, a registered nurse and the authorized representative of (Petitioner), filed a request with the Director ofinsurance and Financial

, a registered nurse and the authorized representative of (Petitioner), filed a request with the Director ofinsurance and Financial y*^s^\ STATE OF MICHIGAN DEPARTMENT OF INSURANCE AND FINANCIAL SERVICES Before the Director of Insurance and Financial Services In the matter of: Petitioner v Alliance Health and Life Insurance Company

More information

School Policy on ADHD and Associated Psychotropic / Psychostimulant Drugs Chris Jenner, December 13, 2007

School Policy on ADHD and Associated Psychotropic / Psychostimulant Drugs Chris Jenner, December 13, 2007 What is ADHD? School Policy on ADHD and Associated Psychotropic / Psychostimulant Drugs Chris Jenner, December 13, 2007 http://www.kidshealth.org/parent/medical/learning/adhd.html Because there's no test

More information

a. Access to practitioners experienced in the diagnosis and management of adult ADHD.

a. Access to practitioners experienced in the diagnosis and management of adult ADHD. NCAA Banned Drugs and Medical Exceptions Policy Guidelines Regarding Medical Reporting for Student-Athletes with Attention Deficit Hyperactivity Disorder (ADHD) Taking Prescribed Stimulants The NCAA bans

More information

South African Foundation Phase Teachers Perceptions of ADHD at Private and Public Schools

South African Foundation Phase Teachers Perceptions of ADHD at Private and Public Schools Supplementary Information South African Foundation Phase Teachers Perceptions of ADHD at Private and Public Schools Psychology School of Human & Community Development Private Bag 3, Wits 2050, South Africa.

More information

Interview for Adult ADHD (Parent or Adult Questionnaire)

Interview for Adult ADHD (Parent or Adult Questionnaire) Interview for Adult ADHD (Parent or Adult Questionnaire) (client s name here) is undergoing evaluation for Attention Deficit Hyperactivity Disorder (ADHD). You have been identified as someone who could

More information

ADHD DSM Criteria and Evidence-based Treatments

ADHD DSM Criteria and Evidence-based Treatments ADHD DSM Criteria and Evidence-based Treatments DSM-5 Criteria for ADHD A. A persistent pattern of inattention and/or hyperactivity-impulsivity that interferes With functioning or development, as characterized

More information

ADHD Stimulant Step Therapy Program

ADHD Stimulant Step Therapy Program ADHD Stimulant Step Therapy Program Policy Number: 5.01.592 Last Review: 7/2016 Origination: 7/2017 Next Review: 7/2017 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

Medication for children with autism

Medication for children with autism Medication for children with autism James Scott Child & Adolescent Psychiatrist Royal Brisbane and Women s Hospital & The University of Queensland Centre for Clinical Research Murray 9 year old boy Autistic

More information

Cognitive Behavior Therapy for Adolescents with Attention Deficit Hyperactivity Disorder. Monica Mongia, PhD Lily Hechtman, MD, F.R.C.

Cognitive Behavior Therapy for Adolescents with Attention Deficit Hyperactivity Disorder. Monica Mongia, PhD Lily Hechtman, MD, F.R.C. Cognitive Behavior Therapy for Adolescents with Attention Deficit Hyperactivity Disorder Monica Mongia, PhD Lily Hechtman, MD, F.R.C.P ADHD in Adolescence Adolescence- Crucial stage of development Inattentiveness,

More information

VERIFICATION FORM for ATTENTION DEFICIT / HYPERACTIVITY DISORDER (AD/HD)

VERIFICATION FORM for ATTENTION DEFICIT / HYPERACTIVITY DISORDER (AD/HD) Verification Form for Attention Deficit / Hyperactivity Disorder (AD/HD) 1 Office for Disability Services The Pennsylvania State University http://equity.psu.edu/ods VERIFICATION FORM for ATTENTION DEFICIT

More information

CRITERIA FOR DIAGNOSIS AND MANAGEMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN ADULTS

CRITERIA FOR DIAGNOSIS AND MANAGEMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN ADULTS CRITERIA FOR DIAGNOSIS AND MANAGEMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER IN ADULTS For the purpose of this document adults are considered to be persons who are 18 years or over. Separate criteria

More information

ADHD Child and Adolescent Clinical Guideline

ADHD Child and Adolescent Clinical Guideline ADHD Child and Adolescent Clinical Guideline ADHD Concern Identified Hyperactive, Impulsivity. Severity and of symptoms. functional impairment rating scales, m amily HX ADHD Diagnosis Only? Develop Treatment

More information

2015 HEDIS/CAHPS Effectiveness of Care Report for 2014 Service Measures Oregon, Idaho and Montana Commercial Business

2015 HEDIS/CAHPS Effectiveness of Care Report for 2014 Service Measures Oregon, Idaho and Montana Commercial Business 2015 HEDIS/CAHPS Effectiveness of Care Report for 2014 Service Measures Oregon, Idaho and Montana Commercial Business About HEDIS The Healthcare Effectiveness Data and Information Set (HEDIS 1 ) is a widely

More information

presented by Dr. Annick Vincent, Clinique du TDAH Institut Universitaire en santé mentale, Centre hospitalier Robert-Giffard Revision : October 2007

presented by Dr. Annick Vincent, Clinique du TDAH Institut Universitaire en santé mentale, Centre hospitalier Robert-Giffard Revision : October 2007 Attention Deficit and Hyperactivity Disorder School adaptation presented by Dr. Annick Vincent, Clinique du TDAH Institut Universitaire en santé mentale, Centre hospitalier Robert-Giffard Revision : October

More information

Attention Deficit Hyperactivity Disorder [ADHD] Formulary Guidance [v1.0]

Attention Deficit Hyperactivity Disorder [ADHD] Formulary Guidance [v1.0] Attention Deficit Hyperactivity Disorder [ADHD] Formulary Guidance [v1.0] 1. Introduction These Guidelines are intended for routine use. However there will be instances where they are not suitable for

More information

Introducing the Department of Health and Mental Hygiene (DHMH) Applied Behavior Analysis (ABA) Medicaid Benefit

Introducing the Department of Health and Mental Hygiene (DHMH) Applied Behavior Analysis (ABA) Medicaid Benefit Introducing the Department of Health and Mental Hygiene (DHMH) Applied Behavior Analysis (ABA) Medicaid Benefit Regional Forums November and December 2016 Presented By: Karl Steinkraus, Director Provider

More information

THE ACADEMIC DIFFERENCE

THE ACADEMIC DIFFERENCE Clinical Update March 2007 Adults with ADHD Attention Deficit Hyperactivity Disorder (ADHD) can persist into or finally be diagnosed in adulthood. Responding to a surge in referrals, SUNY Upstate s Department

More information

written by Harvard Medical School ADHD Attention Deficit Hyperactivity Disorder www.patientedu.org

written by Harvard Medical School ADHD Attention Deficit Hyperactivity Disorder www.patientedu.org written by Harvard Medical School ADHD Attention Deficit Hyperactivity Disorder www.patientedu.org Every child gets restless and fidgety from time to time; in particular, boys are often bursting with energy

More information

Assessment in Childhood: Theory into Practice. Introduction and goals. Types of assessment

Assessment in Childhood: Theory into Practice. Introduction and goals. Types of assessment Assessment in Childhood: Theory into Practice Kent Grelling, PhD Grelling Psychology Associates Orinda, CA Introduction and goals A brief introduction to assessment of children Discuss various types of

More information

Physician's guide for assessing and monitoring cardiovascular risk when prescribing Strattera

Physician's guide for assessing and monitoring cardiovascular risk when prescribing Strattera Physician's guide for assessing and monitoring cardiovascular risk when prescribing Strattera Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of

More information

SAMPLE. Conners 3 Parent Assessment Report. By C. Keith Conners, Ph.D.

SAMPLE. Conners 3 Parent Assessment Report. By C. Keith Conners, Ph.D. By C. Keith Conners, Ph.D. Conners 3 Parent Assessment Report This Assessment report is intended for use by qualified assessors only, and is not to be shown or presented to the respondent or any other

More information

Copyright 2006: www.valueoptions.com Page 1 of 5

Copyright 2006: www.valueoptions.com Page 1 of 5 V-CODES RELATIONAL PROBLEMS DSM-IV-TR Diagnostic Codes: V61.9 Relational Problem Related to a Mental Disorder or General Medical Condition V61.20 Parent-Child Relational Problem V61.10 Partner Relational

More information

Conners' Kiddie Continuous Performance Test (K-CPT V.5)

Conners' Kiddie Continuous Performance Test (K-CPT V.5) Conners' Kiddie Continuous Performance Test (K-CPT V.) By C. Keith Conners, Ph.D. and MHS Staff Profile Report Caution: This report is intended to be used by the test administrator as an interpretive aid.

More information

Parenting Stress Index - Long Form. Computer-Assisted Interpretive Report. Developed By. Richard R. Abidin, EdD and PAR Staff. Demographic Information

Parenting Stress Index - Long Form. Computer-Assisted Interpretive Report. Developed By. Richard R. Abidin, EdD and PAR Staff. Demographic Information Parenting Stress Index - Long Form Computer-Assisted Interpretive Report Developed By Richard R. Abidin, EdD and PAR Staff Demographic Information - Respondent - Name : Sample L. Client Client ID : 123456

More information

Fixing Mental Health Care in America

Fixing Mental Health Care in America Fixing Mental Health Care in America A National Call for Measurement Based Care in Behavioral Health and Primary Care An Issue Brief Released by The Kennedy Forum Prepared by: John Fortney PhD, Rebecca

More information

New Developments in the Treatment of ADHD in Children: How the Pharmacist and Pharmacy Technician Can Impact Care

New Developments in the Treatment of ADHD in Children: How the Pharmacist and Pharmacy Technician Can Impact Care New Developments in the Treatment of ADHD in Children: How the Pharmacist and Pharmacy Technician Can Impact Care Post-Test/Rationale EDUCATIONAL OBJECTIVES Upon completion of this activity, participants

More information

SAMPLE. Conners 3 Self-Report Assessment Report. By C. Keith Conners, Ph.D.

SAMPLE. Conners 3 Self-Report Assessment Report. By C. Keith Conners, Ph.D. By C. Keith Conners, Ph.D. Conners 3 Self-Report Assessment Report This Assessment report is intended for use by qualified assessors only, and is not to be shown or presented to the respondent or any other

More information

Classroom Management and Teaching Strategies. Attention Deficit Hyperactivity Disorder. Allison Gehrling ABSTRACT. Law & Disorder

Classroom Management and Teaching Strategies. Attention Deficit Hyperactivity Disorder. Allison Gehrling ABSTRACT. Law & Disorder Page 43 Law & Disorder Classroom Management and Teaching Strategies for Students with Attention Deficit Hyperactivity Disorder Allison Gehrling Elementary General Education, Senior, Indiana University

More information

Managing people with ADHD and psychosis. Peter Mason Consultant Psychiatrist Adult ADHD Service

Managing people with ADHD and psychosis. Peter Mason Consultant Psychiatrist Adult ADHD Service Managing people with ADHD and psychosis Peter Mason Consultant Psychiatrist Adult ADHD Service Mr A Bipolar affective disorder (no insight) On Lithium and Quetiapine ADHD (late diagnosis age 44) Mr A Bipolar

More information

Cognitive behavioral therapy (CBT) may improve the home behavior of children with Attention Deficit/Hyperactivity Disorder (ADHD).

Cognitive behavioral therapy (CBT) may improve the home behavior of children with Attention Deficit/Hyperactivity Disorder (ADHD). ADHD 4 Cognitive behavioral therapy (CBT) may improve the home behavior of children with Attention Deficit/Hyperactivity Disorder (ADHD). CITATION: Fehlings, D. L., Roberts, W., Humphries, T., Dawe, G.

More information